ELACYT Trademark

Trademark Overview

On Tuesday, February 22, 2005, a trademark application was filed for ELACYT with the United States Patent and Trademark Office. The USPTO has given the ELACYT trademark a serial number of 79010036. The federal status of this trademark filing is IR CANCELLED - NO TRANSFORMATION FILED as of Friday, January 1, 2010. This trademark is owned by CLAVIS PHARMA AS. The ELACYT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical and veterinary preparations for the treatment of cancer, hematological malignancies, infectious diseases, inflammatory diseases, cardiovascular diseases, diabetes, and gastro-intestinal diseases
elacyt

General Information

Serial Number79010036
Word MarkELACYT
Filing DateTuesday, February 22, 2005
Status401 - IR CANCELLED - NO TRANSFORMATION FILED
Status DateFriday, January 1, 2010
Registration Number3127094
Registration DateTuesday, August 8, 2006
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 16, 2006

Trademark Statements

Goods and ServicesPharmaceutical and veterinary preparations for the treatment of cancer, hematological malignancies, infectious diseases, inflammatory diseases, cardiovascular diseases, diabetes, and gastro-intestinal diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, May 13, 2005
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCLAVIS PHARMA ASA
Party Type31 - New Owner After Registration
Legal Entity Type98 - Unknown
AddressNO
Party NameCLAVIS PHARMA AS
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressNO
Party NameCLAVIS PHARMA AS
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressNO
Party NameCLAVIS PHARMA AS
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressNO

Trademark Events

Event DateEvent Description
Monday, September 28, 2009DEATH OF INTERNATIONAL REGISTRATION
Friday, April 3, 2009DEATH OF INTERNATIONAL REGISTRATION
Friday, April 18, 2008FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, April 5, 2007FINAL DISPOSITION NOTICE SENT TO IB
Thursday, April 5, 2007FINAL DISPOSITION PROCESSED
Tuesday, March 27, 2007FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Thursday, December 28, 2006CHANGE OF OWNER RECEIVED FROM IB
Tuesday, November 7, 2006PAPER RECEIVED
Tuesday, August 8, 2006REGISTERED-PRINCIPAL REGISTER
Tuesday, May 16, 2006PUBLISHED FOR OPPOSITION
Wednesday, April 26, 2006NOTICE OF PUBLICATION
Friday, March 31, 2006CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Wednesday, March 22, 2006LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, March 17, 2006ASSIGNED TO LIE
Monday, March 13, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, March 10, 2006TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, March 2, 2006CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 6, 2006PAPER RECEIVED
Thursday, March 2, 2006TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, March 2, 2006TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, November 16, 2005IRREGULARITY FROM IB EXAMINED BY MPU
Friday, October 7, 2005REFUSAL PROCESSED BY IB
Thursday, September 22, 2005IRREGULARITY ON REFUSAL FROM IB
Monday, September 19, 2005NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, September 17, 2005NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, September 16, 2005NON-FINAL ACTION WRITTEN
Friday, September 16, 2005ASSIGNED TO EXAMINER
Friday, May 13, 2005NEW APPLICATION ENTERED IN TRAM
Thursday, May 12, 2005SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

elacyt diseases inflammatory cardiovascular diabetes intestinal gastro infectious malignancies preparations veterinary